Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell, Marginal Zone × Antibodies, Monoclonal × Clear all

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone

NCT00265928 2008-01-28

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Clinical Trials

IBI376 Plus Rituximab in Patients With Untreated Indolent Lymphoma.

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma